Cocrystal Pharma, Inc. (NASDAQ:COCP) Short Interest Update

Cocrystal Pharma, Inc. (NASDAQ:COCP) saw a significant growth in short interest in December. As of December 31st, there was short interest totalling 27,900 shares, a growth of 59.4% from the December 15th total of 17,500 shares. Approximately 0.4% of the shares of the stock are sold short. Based on an average daily trading volume, of 42,300 shares, the short-interest ratio is presently 0.7 days.

Cocrystal Pharma Price Performance

Shares of NASDAQ COCP traded down $0.04 during mid-day trading on Friday, hitting $1.97. 21,713 shares of the stock traded hands, compared to its average volume of 45,319. The company has a market cap of $20.03 million, a PE ratio of -1.06 and a beta of 1.53. Cocrystal Pharma has a twelve month low of $1.33 and a twelve month high of $3.26. The firm has a 50 day simple moving average of $2.15 and a two-hundred day simple moving average of $2.00.

Cocrystal Pharma Company Profile

Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.